S-309309

N/A

Report date: 2024/12/16 16:41:30
NME

Base Information

Drug NameS-309309
Drug Alias NameS-309309
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAlpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase inhibitors
TargetsAlpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase
Therapy Area/IndicationsObesity
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesShionogi & Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShionogi & Co Ltd
Inactive CompaniesN/A
Active IndicationsObesity
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A